Uncategorized
VisionQuest Biomedical’s EyeStar Passes the 30,000-Patient Milestone for Diabetic Retinopathy Screening Using Artificial Intelligence
ALBUQUERQUE, N.M.--(BUSINESS WIRE)-- #ai--VisionQuest Biomedical Inc. announces that the company has screened over 30,000 patients for diabetic retinopathy at the Clínicas del Azúcar in Mexico using the EyeStar artificial intelligence (AI) software. The EyeStar AI system screens patients for diabetic retinopathy and macular edema, conditions that lead to vision loss and blindness if left untreated. VisionQuest brought the EyeStar AI system to Clínicas del Azúcar in 2016, and since then the software h